Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Ethn Subst Abuse ; 22(2): 350-371, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-34339341

RESUMEN

American Indian and Alaska Native (AIAN) communities have higher rates of substance use than other racial and ethnic groups. Substance use disorder (SUD) is tied to the increased risk of experiencing homelessness. National policies have also led to the disproportionate rates of homelessness among AIAN communities. However, specific experiences related to the occurrence of SUD and homelessness among AIAN in California, as well as seeking and accessing SUD treatment, are not well understood. This study explored potential SUD risk and resilience factors for AIANs experiencing homelessness and their experiences when seeking services for SUD. Nineteen interviews were conducted in northern, central, and southern California. Thematic analysis was used for these data. The five primary codes were: (1) risk factors for SUD, (2) resilience related to SUD service seeking, (3) services available, (4) barriers accessing services, and (5) services needed. Based on the results, themes for risk were trauma, mental health, and community conditions. Themes for resilience were identified at individual and community levels and included personal motivation and community support and inclusiveness. Themes for services available were limited knowledge about service types and services' location. The themes for barriers accessing services were identified at internal and external levels, and included lack of readiness and transportation challenges, respectively. Themes for services needed included continuum of care, integrated care, and culturally sensitive services. Findings highlight the importance of addressing the potential risk factors and service needs of AIANs experiencing homelessness to provide comprehensive and culturally sensitive services to reduce substance use.


Asunto(s)
Indio Americano o Nativo de Alaska , Personas con Mala Vivienda , Trastornos Relacionados con Sustancias , Humanos , Indio Americano o Nativo de Alaska/psicología , California , Trastornos Relacionados con Sustancias/epidemiología
2.
J Endocrinol Invest ; 44(6): 1151-1158, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33111215

RESUMEN

CONTEXT: Gender incongruence is defined as disharmony between assigned gender and gender identity. Several interventions are liable in this case including genital affirming surgery among other surgical interventions such as harmonization, and also the use of gonadotropin-releasing hormone agonists (GnRHa) for gonadal shielding. This aids in preventing the development of secondary sexual characteristics related to the genetic sex. OBJECTIVE: Systematically review the treatment of gender incongruity with GnRHa analogues. DATA SOURCES: The data source of this research is from Pubmed-Medline and Embase. STUDY SELECTION: Articles published between 2009 and 2019 which studied transgender adolescents treated with GnRHa were carefully selected. DATA EXTRACTION: Were extracted: design, sample size, study context, targeted subjects of intervention, outcome measures, and results. RESULTS: Eleven studies were included. The use of GnRHa seems to be well tolerated by the studied population. When started in pubertal transition, it was associated with a more distinct resemblance to body shape than to the affirmed sex. In addition to preventing the irreversible phenotypic changes that occur in cross-hormonal therapy, the use of GnRHa can equally contribute to the mental health of these adolescents. LIMITATION: There are few consistent studies on the use of GnRHa for gender incongruence. CONCLUSION: As the population of transgender children and adolescents grows, they acquire knowledge and greater access to the various forms and stages of treatment for sex reassignment. The medical community needs to be adequately prepared to better serve this population and offer the safest resources available.


Asunto(s)
Disforia de Género , Hormona Liberadora de Gonadotropina/agonistas , Pubertad , Adolescente , Disruptores Endocrinos/farmacología , Disforia de Género/metabolismo , Disforia de Género/fisiopatología , Disforia de Género/prevención & control , Humanos , Pubertad/efectos de los fármacos , Pubertad/fisiología , Desarrollo Sexual/efectos de los fármacos , Desarrollo Sexual/fisiología , Personas Transgénero
3.
Arthritis Rheum ; 42(10): 2189-93, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10524692

RESUMEN

OBJECTIVE: To assess objective and subjective evidence of sleep disorders in patients with systemic lupus erythematosus (SLE) and to examine correlations between parameters of lupus activity, depression, and sleep disturbances. METHODS: Fourteen SLE patients and 11 normal control subjects of similar age underwent all-night polysomnography on 3 consecutive nights. The patients and controls were also evaluated for daytime sleepiness by the Multiple Sleep Latency Test and completed a sleep disorders questionnaire and the Beck Depression Inventory. RESULTS: The polysomnographic data showed that sleep in SLE patients was characterized by respiratory and movement disorders. These intrinsic primary sleep disorders are related to the symptom of restless, poor sleep at night. Lupus patients were more sleepy during the day, and their sleepiness was related to sleep fragmentation, with more arousals and stage transitions than the control group. Disease activity was associated with decreases in sleep efficiency and delta sleep and with increases in sleep fragmentation. Depression was not correlated with the activity of the disease. CONCLUSION: There is an enhanced presence of sleep disorders in patients with SLE. The most frequent primary sleep disorders are respiratory and movement disorders.


Asunto(s)
Lupus Eritematoso Sistémico/complicaciones , Trastornos del Sueño-Vigilia/etiología , Trastornos del Sueño-Vigilia/psicología , Adulto , Depresión/complicaciones , Femenino , Humanos , Lupus Eritematoso Sistémico/fisiopatología , Persona de Mediana Edad , Pacientes Ambulatorios
4.
J Med Genet ; 15(2): 116-8, 1978 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-641943

RESUMEN

A family with Becker type muscular dystrophy is described, in which two females were severely affected, giving the family tree the appearance of dominant inheritance.


Asunto(s)
Genes Dominantes , Distrofias Musculares/genética , Adolescente , Adulto , Femenino , Ligamiento Genético , Humanos , Masculino , Persona de Mediana Edad , Linaje , Factores Sexuales , Cromosoma X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA